Vicarious Surgical Inc.
Vicarious Surgical Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash And Cash Equivalents At Carrying Value | 3 | 3 | 4 | 3 | 10 | 7 | 20 | 38 | 53 | 59 | 33 | 54 | |||||
Assets Current | |||||||||||||||||
Assets Current | 12 | 15 | 26 | 40 | 52 | 64 | 76 | 87 | 101 | 113 | 85 | 101 | |||||
Short Term Investments | 7 | 10 | 20 | 35 | 39 | 54 | 53 | 46 | 45 | 51 | 50 | 43 | |||||
Prepaid Expense Current | - | - | - | - | - | - | - | - | - | - | 2 | 4 | |||||
Prepaid Expense And Other Assets Current | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | - | - | |||||
Restricted Cash Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Property Plant And Equipment Net | 1 | 3 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | |||||
Operating Lease Right Of Use Asset | 6 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 12 | 12 | 12 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 20 | 29 | 41 | 55 | 68 | 81 | 93 | 105 | 120 | 132 | 105 | 121 | |||||
Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | |||||
Accrued Liabilities Current | 1 | 1 | 3 | 6 | 5 | 5 | 5 | 3 | 5 | 5 | 5 | 4 | |||||
Capital Lease Obligations Current | - | - | - | - | - | - | - | 1 | - | - | - | 0 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 4 | 3 | 5 | 8 | 8 | 9 | 7 | 5 | 7 | 8 | 7 | 7 | |||||
Other Notes Payable Current | 1 | - | - | - | - | - | - | - | - | - | - | - | |||||
Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | 1 | 1 | 1 | 1 | |||||
Finance Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 14 | 15 | |||||
Operating Lease Liability Noncurrent | 6 | 12 | 12 | 12 | 13 | 13 | 13 | 14 | 14 | 14 | - | - | |||||
Warrants And Rights Outstanding | - | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 7 | 12 | |||||
Liabilities | 10 | 15 | 18 | 21 | 21 | 23 | 21 | 21 | 22 | 24 | 29 | 33 | |||||
Common Stock Value | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Additional Paid In Capital | 256 | 250 | 248 | 245 | 243 | 240 | 237 | 234 | 231 | 228 | 180 | 176 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | 10 | 14 | 23 | 34 | 47 | 58 | 72 | 84 | 98 | 108 | 76 | 88 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 0 | 0 | - | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -0 | 0 | |||||
Retained Earnings Accumulated Deficit | -246 | -236 | -225 | -211 | -196 | -182 | -165 | -150 | -133 | -120 | -104 | -89 | |||||
Liabilities And Stockholders Equity | 20 | 29 | 41 | 55 | 68 | 81 | 93 | 105 | 120 | 132 | 105 | 121 | |||||
Common Class A | 0 | 1 | 0 | 5 | 0 | 5 | -127 | 128 | 0 | 155 | -107 | 107 | |||||
Common Class B | 0 | 0 | 0 | 1 | 0 | 0 | -19 | 20 | 0 | 0 | 0 | 20 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -14.54% | -14.21% | -2.25% | -45.02% | -31.79% | -48.50% | -27.67% | -38.83% | -46.60% | 102.16% | 26.68% | 142.59% |
| 2024 | 25.00% | -17.14% | -6.55% | 10.75% | 9.60% | 55.09% | 44.43% | 31.15% | 19.75% | -44.76% | -10.49% | -21.29% |
| 2023 | 4.27% | -13.27% | -22.27% | -43.72% | -50.79% | -73.84% | -30.21% | 8.33% | 4.69% | -16.11% | -25.00% | -2.78% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.97 | 4.75 | 5.11 | 5.05 | 6.74 | 7.44 | 10.57 | 17.16 | 13.87 | 14.53 | 11.39 | 15.20 | |||||
| Quick Ratio | 2.51 | 4.22 | 4.70 | 4.76 | 6.40 | 7.07 | 10.20 | 16.57 | 13.49 | 14.12 | 11.05 | 14.63 | |||||
| Working Capital | 7.68M | 11.90M | 20.97M | 31.80M | 44.03M | 55.37M | 68.75M | 82.04M | 93.67M | 105.61M | 77.79M | 94.74M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.99 | 1.08 | 0.77 | 0.62 | 0.45 | 0.39 | 0.30 | 0.25 | 0.22 | 0.22 | 0.38 | 0.38 | |||||
| Interest Coverage TTM | - | - | - | - | - | -3,050.82 | -3,074.57 | -3,102.50 | -3,226.64 | -752.06 | -601.01 | -489.61 | |||||
| Debt Ratio | 0.50 | 0.52 | 0.44 | 0.38 | 0.31 | 0.28 | 0.23 | 0.20 | 0.18 | 0.18 | 0.28 | 0.28 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -8.19 | -9.00 | -10.04 | -10.40 | -10.74 | -10.58 | -10.39 | -10.44 | -14.60 | -13.37 | -18.47 | -15.31 | |||||
| Free Cash Flow Per Share TTM | -7.35 | -7.99 | -8.38 | -7.98 | -8.49 | -8.58 | -9.42 | -10.17 | -13.14 | -13.72 | -16.11 | -16.34 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | -20.63% | -14.12% | -2.29% | 0.76% | -11.04% | -9.74% | -21.94% | -4.89% | -1,478.15% | -291.65% | -598.28% | -712.10% | |||||
| EPS Growth (1Y) | -23.80% | -14.91% | -3.36% | -0.38% | -26.44% | -20.88% | -43.74% | -31.79% | -1,248.44% | -250.52% | -575.63% | -683.71% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.27 | -0.61 | -0.75 | -0.63 | -1.23 | -0.54 | -0.56 | -0.87 | -0.75 | -1.33 | -2.97 | -4.45 | |||||
| P/B TTM | 1.35 | 2.33 | 1.93 | 1.14 | 1.66 | 0.58 | 0.48 | 0.63 | 0.55 | 0.85 | 3.07 | 3.26 | |||||
| Market Cap | 13.30M | 32.81M | 44.54M | 38.86M | 77.45M | 33.51M | 34.47M | 53.06M | 53.58M | 91.69M | 232.40M | 286.03M | |||||
| Enterprise Value | 9.80M | 28.71M | 39.69M | 35.33M | 66.78M | 25.50M | 13.29M | 14.99M | -173.65K | 31.64M | 212.98M | 245.61M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -45.08M | -47.56M | -49.78M | -47.28M | -49.97M | -50.59M | -55.30M | -59.57M | -63.98M | -70.97M | -68.19M | -68.65M | |||||
| Net Debt | -3.51M | -4.10M | -4.85M | -3.54M | -10.67M | -8.01M | -21.19M | -38.07M | -53.76M | -60.05M | -19.41M | -40.42M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Vicarious Surgical Inc. (RBOT) — SEC Financial Statements & Analysis
Vicarious Surgical Inc. (RBOT) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. Vicarious Surgical Inc. trades on OTC as: RBOT, RBOTW. Based on its latest SEC filing (Form 10-Q, period ending 2025-12-31), Vicarious Surgical Inc. reported a Debt-to-Equity ratio of 0.99x, a Price-to-Book (P/B) ratio of 1.35x (TTM), at a market cap of $13.30M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.99x
- P/B TTM
- 1.35x
- Market Cap
- $13.30M
Data as of 2025-12-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Vicarious Surgical Inc. in?
Vicarious Surgical Inc. (RBOT) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.
What is RBOT's market cap?
Vicarious Surgical Inc. (RBOT) has a market capitalization of $13.30M as of 2025-12-31.
What exchange does RBOT trade on?
Vicarious Surgical Inc. (RBOT) trades on the OTC.
Where is Vicarious Surgical Inc. incorporated?
Vicarious Surgical Inc. is incorporated in DE.